Tumours of the uterine cervix that can be underdiagnosed or misinterpreted

Current Diagnostic Pathology

Volumn 9, Issue 1, 2003, Pages 56-70

  Al Nafussi, A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Cancer; Misdiagnosis; Neoplasm; Underdiagnosis; Uterine cervix

Indexed keywords

ADENOCARCINOMA; ADENOID CYSTIC CARCINOMA; ADENOMA; ENDOMETRIOSIS; ENDOMETRIUM SARCOMA; FEMALE; HUMAN; HUMAN TISSUE; LEIOMYOSARCOMA; MELANOMA; PROGNOSIS; REVIEW; RHABDOMYOSARCOMA; SQUAMOUS CELL CARCINOMA; TUMOR DIAGNOSIS; UTERINE CERVIX TUMOR;

EID: 0037307899     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2003.0156     Document Type: Review

References (137)

1. Wright TC, Ferenczy A, Kurman RJ. Carcinoma and other tumours of the cervix. In: Robert J (ed.). Blaustein's Pathology of the Female Genital Tract, 4th edn. New York: Springer-Verlag, J 1994; 279-326.
2. Al-Nafussi AI, Hughes DE. Histological features of CIN 3 and their value in predicting invasive microinvasive squamous carcinoma. J Clin Pathol 1994; 47: 799-804.
3. Al Nafussi AI, Monaghan H. Squamous carcinoma of the uterine cervix with CIN 3-like growth pattern: An under-diagnosed lesion. Int J Gynecol Cancer 2000; 10: 95-99.
4. Fukushima M, Shimano S, Yamakawa Y. The detection of human papillomavirus (HPV) in a case of minimal deviation adenocarcinoma of the uterine cervix (adenoma malignum) using in situ hybridization. Jpn J Clin Oncol 1990; 20: 407-412.
5. Katabuchi H, Aragane F, Fukumatsu Y, Matsuura K, Ito M, Okamura H. [Clinical and histologic features of minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix]. Nippon Sanka Fujinka Gakkai Zasshi 1991; 43: 567-570.
6. Gilks CB, Young RH, Aguirre P, DeLellis RA, Scully RE. Adenoma malignum (minimal deviation adenocarcinoma) of the uterine cervix. A clinicopathological and immunohistochemical analysis of 26 cases. Am J Surg Pathol 1989; 13: 717-729.
7. Young RH, Scully RE. Minimal-deviation endometrioid adenocarcinoma of the uterine cervix. A report of five cases of a distinctive neoplasm that may be misinterpreted as benign. Am J Surg Pathol 1993; 17: 660-665.
8. Nishida, T., Ushijima, K., Oda, T et al. Minimal deviation adenocarcinoma (adenoma malignum) of the uterine cervix associated with mucinous ovarian carcinoma. Kurume Med J 1991; 38: 265-269.
9. Cheah PL, Looi LM. Carcinoma of the uterine cervix: a review of its pathology and commentary on the problem in Malaysians. Malays J Pathol 1999; 21: 1-15.
10. Hirai Y, Takeshima N, Haga, A, Arai Y, Akiyama F, Hasumi K. A clinicocytopathologic study of adenoma malignum of the uterine cervix. Gynecol Oncol 1998; 70: 219-223.
11. Young RH, Clement PB. Malignant lesions of the female genital tract and peritoneum that may be underdiagnosed. Semin Diagn Pathol 1995; 12: 14-29.
12. Chatti S, Bellil K, Jerbi G et al. [Minimal deviation adenocarcinoma of the uterine cervix in a woman with Peutz-Jeghers syndrome. Report of a case]. Ann Pathol 1997; 17: 193-195.
13. Ichimura T, Koizumi T, Tateiwa H et al. Immunohistochemical expression of gastric mucin and p53 in minimal deviation adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 2000; 20: 220-226.
14. Matseoane S, Moscovic E, Williams S, Huang JC. Mucinous neoplasm in the cervix associated with a mucinous neoplasm in the ovary and concurrent bilateral sex cord tumors with annular tubules: immunohistochemical study. Gynecol Oncol 1991; 43: 300-304.
15. Kudo R, Sagae S, Kusanagi T, Mizuuchi H, Hayakawa O, Hashimoto M. Minimal-deviation adenocarcinoma (adenoma malignum) of the uterine cervix; four case reports. Eur J Obstet Gynecol Reprod Biol 1990; 34: 179-188.
16. Toki T, Shiozawa T, Hosaka N, Ishii K, Nikaido T, Fujii S. Minimal deviation adenocarcinoma of the uterine cervix has abnormal expression of sex steroid receptors, CA125, and gastric mucin. Int J Gynecol Pathol 1997; 16: 111-116.
17. Hayashi I, Tsuda H, Shimoda T. Reappraisal of orthodox histochemistry for the diagnosis of minimal deviation adenocarcinoma of the cervix. Am J Surg Pathol 2000; 24: 559-562.
18. Ishii K, Hosaka N, Toki T et al. A new view of the so-called adenoma malignum of the uterine cervix. Virchows Arch 1998; 432: 315-322.
19. Steeper TA, Wick MR. Minimal deviation adenocarcinoma of the uterine cervix ('adenoma malignum'). An immunohistochemical comparison with microglandular endocervical hyperplasia and conventional endocervical adenocarcinoma. Cancer 1986; 58: 1131-1138.
20. Sato S, Ito K, Konno R, Okamoto S, Yajima A. Adenoma malignum. Report of a case with cytologic and colposcopic findings and immunohistochemical staining with antimucin monoclonal antibody HIK-1083. Acta Cytol 2000; 44: 389-392.
21. Young RH, Clement PB. Endocervicosis involving the uterine cervix: a report of four cases of a benign process that may be confused with deeply invasive endocervical adenocarcinoma. Int J Gynecol Pathol 2000; 19: 322-328.
22. Yoden E, Mikami Y, Fujiwara K, Kohno I, Imajo Y. Florid endocervical glandular hyperplasia with pyloric gland metaplasia: a radiologic pitfall. J Comput Assist Tomogr 2001; 25: 94-97.
23. Nucci MR, Clement PB, Young RH. Lobular endocervical glandular hyperplasia, not otherwise specified: a clinicopathologic analysis of thirteen cases of a distinctive pseudoneoplastic lesion and comparison with fourteen cases of adenoma malignum. Am J Surg Pathol 1999; 23: 886-891.
24. Seidman JD, Tavassoli FA. Mesonephric hyperplasia of the uterine cervix: a clinicopathologic study of 51 cases. Int J Gynecol Pathol 1995; 14: 293-299.
25. Jones MA, Young RH, Scully RE. Diffuse faminar endocervical glandular hyperplasia. A benign lesion often confused with adenoma malignum (minimal deviation adenocarcinoma). Am J Surg Pathol 1991; 15: 1123-1129.
26. Clement PB, Young RH. Deep nabothian cysts of the uterine cervix. A possible source of confusion with minimal-deviation adenocarcinoma (adenoma malignum). Int J Gynecol Pathol 1989; 8: 340-348.
27. Rahilly MA, Williams AR, al Nafussi, A. Minimal deviation endometrioid adenocarcinoma of cervix: a clinicopathological and immunohistochemical study of two cases. Histopathology 1992; 20: 351-354.
28. Young RH, Scully RE. Villoglandular papillary adenocarcinoma of the uterine cervix. A clinicopathologic analysis of 13 cases. Cancer 1989; 63: 1773-1779.
29. Jones MW, Kounelis S, Papadaki H et al. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: oncogene/tumor suppressor gene alterations and human papillomavirus genotyping. Int J Gynecol Pathol 2000; 19: 110-117.
30. Jones MW, Silverberg SG, Kurman RJ. Well-differentiated villoglandular adenocarcinoma of the uterine cervix: a clinicopathological study of 24 cases. Int J Gynecol Pathol 1993; 12: 1-7.
31. Skopelitou A, Hadjiyannakis M. Enteric type villoglandular papillary adenocarcinoma of the uterine cervix associated with in situ squamous cell carcinoma. Case report and review of the literature. Eur J Gynaecol Oncol 1996; 17: 309-14.
32. Lu FH, Chen BF, Yang YC. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report. Chung Hua I Hsueh Tsa Chih (Taipei) 1998; 61: 436-440.
33. Borgo G, Feyles E, Gaglio A, Tagliani L, Andrion A. Villoglandular papillary adenocarcinoma of the uterine cervix: report of a case. Tumori 1998; 84: 717-719.
34. Collinet P, Prolongeau JF, Vaneecloo S. Villoglandular papillary adenocarcinoma of the uterine cervix. Eur J Obstet Gynecol Reprod Biol 1999; 86: 101-103.
35. Lakhtakia R, Singh MK, Taneja P, Kapila K, Kumar S. Villoglandular papillary adenocarcinoma of the cervix: case report. J Surg Oncol 2000; 74: 297-299.
36. Alfsen GC, Thoresen SO, Kristensen GB, Skovlund E, Abeler VM. Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: a population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 2000; 89: 1291-1299.
37. Stanley-Christian H, Heim BK, Hines JF, Hall KL, Willett GD, Barnes WA. Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature. Gynecol Oncol 1997; 66: 327-330.
38. Datta CK. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix. WV Med J 1997; 93: 186-188.
39. Bouman A, Oosterhuis GJ, Naudin ten Cate, van Doorn GA. Villoglandular papillary adenocarcinoma of the cervix. Beware of a wolf in sheep's clothing. Eur J Obstet Gynecol Reprod Biol 1999; 87: 183-189.
40. Al Nafussi A, Obafunwa J, Jordan LB, Fulton I, Martin C, Beattie G. Cervical implant from villoglandular endometrial adenocarcinoma masquerading as cervical villoglandular adenocarcinoma. Int J Gynecol Cancer 2002; 12: 308-311.
41. Daroca PJ Jr, Dhurandhar HN. Basaloid carcinoma of uterine cervix. Am J Surg Pathol 1980; 4: 235-239.
42. Grayson W, Taylor LF, Cooper K. Adenoid cystic and adenoid basal carcinoma of the uterine cervix: comparative morphologic, mucin, and immunohistochemical profile of two rare neoplasms of putative 'reserve cell' origin. Am J Surg Pathol 1999; 23: 448-458.
43. Brainard JA, Hart WR. Adenoid basal epitheliomas of the uterine cervix: a reevaluation of distinctive cervical basaloid lesions currently classified as adenoid basal carcinoma and adenoid basal hyperplasia. Am J Surg Pathol 1998; 22: 965-975.
44. Senzaki H, Osaki T, Uemura Y et al. Adenoid basal carcinoma of the uterine cervix: immunohistochemical study and literature review. Jpn J Clin Oncol 1997; 27: 437-441.
45. Yoshida T, Fujiwara K, Shimizu M, Kohno I, Mikami Y, Manabe T. Adenoid basal carcinoma of the cervix uteri: a case report. Pathol Int 1997; 47: 775-777.
46. Albores-Saavedra J, Manivel C, Mora A, Vuitch F, Milchgrub S, Gould E. The solid variant of adenoid cystic carcinoma of the cervix. Int J Gynecol Pathol 1992; 11: 2-10.
47. Ferry JA, Scully RE. 'Adenoid cystic' carcinoma and adenoid basal carcinoma of the uterine cervix. A study of 28 cases. Am J Surg Pathol 1988; 12: 134-144.
48. Al Nafussi AI, Al Yusif R. Papillary squamotransitional cell carcinoma of the uterine cervix: an advanced stage disease despite superficial location: report of two cases and review of the literature. Eur J Gynaecol Oncol 1998; 19: 455-457.
49. Randell ME, Anderson WA, Mills SE, Kim JAC. Papillary squamous cell carcinoma of the uterine cervix: A clinicopathologic study of 9 cases. Int J Gynecol Pathol 1986; 5: 1-10
50. Albores-Saavedra J, Young RH. Transitional cell neoplasms (carcinomas and inverted papillomas) of the uterine cervix. A report of five cases. Am J Surg Pathol 1995; 19: 1138-1145.
51. Sulaiman RA, Manivel JC. Papillary transitional cell carcinoma (TCC) of the uterine cervix and its histological mimics. Lab Investig 1996; 74: Abstract No. 568.
52. Koenig C, Turnicky RP, Kankam CF, Tavassoli FA. Papillary squamotransitional cell carcinoma of the cervix. A report of 32 cases. Am J Surg Pathol 1997; 21: 915-921.
53. Chen KT, Bocian JJ. Squamous papilloma arising in cervical ectropion associated with intrauterine diethylstilbestrol exposure. Diagn Gynecol Obstet 1982; 4: 137-139.
54. Silverstone H. Squamous papilloma of the cervix uteri. A two year prospective cytological study. Med J Aust 1975; 2: 304-306.
55. Kistner RW, Hertig AT. Papillomas of the uterine cervix - their malignant potentiality. Obstetr Gynecol 1955; 6: 147-161.
56. Fukunaga M, Ishihara A, Ushigome S. Extrauterine low-grade endometrial stromal sarcoma: report of three cases. Pathol Int 1998; 48: 297-302.
57. Chang KL, Crabtree GS, Lim-Tan SK, Kempson RL, Hendrickson MR. Primary extrauterine endometrial stromal neoplasms: a clinicopathologic study of 20 cases and a review of the literature. Int J Gynecol Pathol 1993; 12: 282-296.
58. Kondi-Paphitis A, Smyrniotis B, Liapis A, Kontoyanni A, Deligeorgi H. Stromal sarcoma arising on endometriosis. A clinicopathological and immunohistochemical study of 4 cases. Eur J Gynaecol Oncol 1998; 19: 588-590.
59. Mourra N, Tiret E, Parc Y, Saint-Maur P, Parc R, Flejou JF. Endometrial stromal sarcoma of the rectosigmoid colon arising in extragonadal endometriosis and revealed by portal vein thrombosis. Arch Pathol Lab Med 2001; 125: 1088-1090.
60. Boardman CH, Webb MJ, Jefferies JA. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer. Gynecol Oncol 2000; 79: 120-123.
61. Chang YC, Wang TY, Tzen CY. Endometrial stromal sarcoma of the vagina [In Process Citation]. Chung Hua I Hsueh Tsa Chih (Taipei) 2000; 63: 714-719.
62. Urban H, Katenkamp D. [Endometrial stromal sarcoma of vaginal and para-vaginal localization. Morphology, diagnosis and differential diagnosis]. Zentralbl Allg Pathol 1988; 134: 511-517.
63. Berkowitz RS, Ehrmann RL, Knapp RC. Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol 1978; 51: 34s-37s.
64. Irvin, W, Pelkey, T, Rice L, Andersen W. Endometrial stromal sarcoma of the vulva arising in extraovarian endometriosis: a case report and literature review. Gynecol Oncol 1998; 71: 313-316.
65. Kim YH, Cho H, Kyeom-Kim H, Kim I. Uterine endometrial stromal sarcoma with rhabdoid and smooth muscle differentiation. J Korean Med Sci 1996; 11: 88-93.
66. Clement PB, Scully RE. Endometrial stromal sarcomas of the uterus with extensive endometrioid glandular differentiation: a report of three cases that caused problems in differential diagnosis. Int J Gynecol Pathol 1992; 11: 163-173.
67. Goldblum JR, Clement PB, Hart WR. Adenomyosis with sparse glands. A potential mimic of low-grade endometrial stromal sarcoma. Am J Clin Pathol 1995; 103: 218-223.
68. Clement PB, Young RH, Scully RE. Stromal endometriosis of the uterine cervix. A variant of endometriosis that may simulate a sarcoma. Am J Surg Pathol 1990; 14: 449-455.
69. Scolyer RA, Carter J, Russell P. Aggressive endometriosis: report of a case. Int J Gynecol Cancer 2000; 10: 257-262.
70. Levine PH, Abou-Nassar S, Mittal K. Extrauterine low-grade endometrial stromal sarcoma with florid endometrioid glandular differentiation. Int J Gynecol Pathol 2001; 20: 395-398.
71. Huber M, Wierrani F, Bohm G, Hauck H, Lintner F, Grunberger W. Multiple endometrial stromal nodules with sparse cysts and glands in the lung - a nodular variation of endometriosis that may mimic metastases of sarcoma. Pathol Res Pract 1999; 195: 59-64.
72. Jordan LB, Al Nafussi A. Clinicopathological study of the pattern and significance of cervical involvement in cases of endometrial adenocarcinoma. Int J Gynecol Cancer 2002; 12: 42-48.
73. Ambros RA, Ballouk F, Malfetano JH, Ross JS. Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus. Am J Surg Pathol 1994; 18: 569-575.
74. Zaino RJ, Kurman RJ, Brunetto VL et al. Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study. Am J Surg Pathol 1998; 22: 1379-1385.
75. Ambros RA, Malfetano JH Villoglandular adenocarcinoma of the endometrium. Am J Surg Pathol 2000; 24: 155-156.
76. O'Hanlan KA, Levine PA, Harbatkin D et al. Virulence of papillary endometrial carcinoma. Gynecol Oncol 1990; 37: 112-119.
77. Symonds DA. Prognostic value of pathologic features and DNA analysis in endometrial carcinoma. Gynecol Oncol 1990; 39: 272-276.
78. Chen JL, Trost DC, Wilkinson EJ. Endometrial papillary adenocarcinoma: Two clinicopathological types. Int J Gynecol Pathol 1985; 4: 279-288.
79. Zaloudek C, Hayashi GM, Ryan IP, Powell CB, Miller TR Microglandular adenocarcinoma of the endometrium: A form of mucinous adenocarcinoma that may be confused with microglandular hyperplasia of the cervix. Int J Gynecol Pathology, 1997; 52-59.
80. McCluggage WG, Perenyei M. Microglandular adenocarcinoma of the endometrium. Histopathology 2000; 37: 285-287.
81. Fukunaga M. Mucinous endometrial adenocarcinoma simulating microglandular hyperplasia of the cervix. Pathol Int 2000; 50: 541-545.
82. Clement PB, Young RH. Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects. Adv Anat Pathol 2002; 9: 145-184.
83. Guarino M, Giordano F, Pallotti F, Polizzotti G, Tricomi P, Cristofori E. Malignant mixed mullerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis. Tumori 1998; 84: 391-397.
84. Auerbach, HE, LiVolsi, VA., Merino, MJ. Malignant mixed Mullerian tumors of the uterus. An immunohistochemical study. Int J Gynecol Pathol 1988; 7: 123-130.
85. Pautier P, Genestie C, Rey A et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer 2000; 88: 1425-1431.
86. Clement PB, Zubovits JT, Young RH, Scully RE. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus. Int J Gynecol Pathol 1998; 17: 211-222.
87. Chen KT, Wolk RW. Extragenital malignant mixed mullerian tumor. Gynecol Oncol 1988; 30: 422-426.
88. Lim SC, Kim DC, Suh CH, Kee KH, Choi SJ. Malignant mixed Mullerian tumor (homologous type) of the adnexa with neuroendocrine differentiation: a case report. J Korean Med Sci 1998; 13: 207-210.
89. Mathoulin-Portier MP, Penault-Llorca F, Labit-Bouvier C et al. Malignant mullerian mixed tumor of the uterine cervix with adenoid cystic component. Int J Gynecol Pathol 1998 17: 91-92.
90. Al Nafussi AI, Hughes DE, Williams AR. Hyaline globules in ovarian tumours. Histopathology 1993; 23: 563-566.
91. Emoto M, Iwasaki H, Kikuchi M, Shirakawa K. Characteristics of cloned cells of mixed mullerian tumor of the human uterus. Carcinoma cells showing myogenic differentiation in vitro. Cancer 1993; 71: 3065-3075.
92. Emoto K, Iwasaki H, Oshima K, Kikuchi M, Kaneko Y, Kawarabayashi T. Characteristics of rhabdomyosarcoma cell lines derived from uterine carcinosarcomas. Virchows Arch. 1997; 431: 249-256.
93. Clement PB. Chondrosarcoma of the uterus: report of a case and review of the literature. Hum Pathol 1978; 9: 726-732.
94. Zhou C, Gilks CB, Hayes M, Clement PB. Papillary serous carcinoma of the uterine cervix: a clinicopathologic study of 17 cases. Am J Surg Pathol 1998; 22: 113-120.
95. Rose PG, Reale FR. Serous papillary carcinoma of the cervix. Gynecol Oncol 1993 50: 361-364.
96. Hendrickson M, Ross J, Eifel PJ, Cox RS, Martinez A, Kempson R. Adenocarcinoma of the endometrium: analysis of 256 cases with carcinoma limited to the uterine corpus. Gynecol Oncol 1982; 13: 373-392.
97. Hendrickson M, Ross J, Eifel P, Martinez A, Kempson R. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma. Am J Surg Path 1982; 6: 93-108.
98. Grice J, Marit E, Greer B et al. Uterine papillary serous carcinoma: evaluation of long-term survival in surgically staged patients. Gynecol Oncol 1998; 69: 69-73.
99. Fitzgerald D, Rosenthal S. Uterine papillary serous carcinoma: complete response to combination chemotherapy. Cancer 1984; 56: 1023-1024.
100. Jordan LB, Abdul-Kader M, Al Nafussi A. Uterine serous papillary carcinoma: histopathologic changes within the female genital tract. Int J Gynecol Cancer 2001; 11: 283-289.
101. Price FV, Rajnikant AM, Sumkin J. Complete clinical responses to neoadjuvant chemotherapy for uterine serous carcinoma. Gynecol Oncol 73: 140-144.
102. Buscema J, Carpenter S E, Rosenshein N B, Woodruff D. Epithelioid leiomyosarcoma of the uterus. Cancer 1986; 57: 1192-1196.
103. Nguyen GK, Russell L, Honore L, Vriends R. Epithelioid leiomyosarcoma of the uterus with oncocytic change. Pathol Res Pract 2001; 197: 643-646.
104. Aru A, Norup P, Bjerregaard B, Andreasson B, Horn T. Osteoclast-like giant cells in leiomyomatous tumors of the uterus. A case report and review of the literature. Acta Obstet Gynecol Scand 2001; 80: 371-4
105. Kasamatsu T, Shiromizu K, Takahashi M, Kikuchi A, Uehara T. Leiomyosarcoma of the uterine cervix. Gynecol Oncol 1998; 69: 169-171.
106. Gotoh Y, Kikuchi M, Takano T, Kita S, Ogata S, Aida S. Epithelioid leiomyosarcoma of the uterine cervix. Gynecol Oncol 2001; 82: 400-405.
107. Colombat M, Sevestre H, Gontier MF. [Epithelioid leiomyosarcoma of the uterine cervix. Report of a case]. Ann Pathol 2001; 21: 48-50.
108. Fujiwaki R, Yoshida M, Iida K, Ohnishi Y, Ryuko K, Miyazaki K. Epithelioid leiomyosarcoma of the uterine cervix. Acta Obstet Gynecol Scand 1998; 77: 246-248.
109. Iwata J, Fletcher CD. Immunohistochemical detection of cytokeratin and epithelial membrane antigen in leiomyosarcoma: a systematic study of 100 cases. Pathol Int 2000; 50: 7-14.
110. Rubin BP, Fletcher CD. Myxoid leiomyosarcoma of soft tissue, an underrecognized variant. Am J Surg Pathol 2000; 24: 927-936.
111. Shroff CP, Deodhar KP, Bhagwat A G. Myxoid leiomyosarcoma of the uterus - a case report with light microscopic and ultrastructural appraisal. Tumori 1984; 70: 561-566.
112. King M, Dickersin G, Scully R. Myxoid leiomyosarcoma of the uterus. A report of six cases. Am J Surg Pathol 1982; 6: 589-598.
113. Toki N, Kashimura, M., Hasegawa, T et al. Myxoid leiomyosarcoma of the uterus. Report of a case with cytologic findings. Acta Cytol 2000; 44: 415-419.
114. Kasahara K, Nishida M, Iijima S, Kaneko M. Uterine myxoid leiomyosarcoma. Obstet Gynecol 2000; 95: 1004-1006.
115. Fraga M, Prieto O, Garcia-Caballero T, Beiras A, Forteza J. Myxoid leiomyosarcoma of the uterine cervix. Histopathology 1994; 25: 381-384.
116. Leuschner I, Harms D, Mattke A, Koscielniak E, Treuner J. Rhabdomyosarcoma of the urinary bladder and vagina: a clinicopathologic study with emphasis on recurrent disease: a report from the Kiel Pediatric Tumor Registry and the German CWS Study. Am J Surg Pathol 2001; 25: 856-864.
117. Masih K, Prabhakar BR. Sarcoma botryoides of the vagina. J Indian Med Assoc 1993; 91: 43.
118. Daya DA, Scully RE. Sarcoma botryoides of the uterine cervix in young women: a clinicopathological study of 13 cases. Gynecol Oncol 1988; 29: 290-304.
119. Chang WC, Lin WC, Lee HC et al. Pure rhabdomyosarcoma of the corpus uteri in a postpartum patient: report of a case and review of the literature. Zhonghua Yi Xue Za Zhi (Taipei) 1992; 50: 73-76.
120. Shu WH, Chang TC, Hsueh S, Kuo TT. Embryonal rhabdomyosarcoma of the uterine corpus mistaken for small cell carcinoma: a case report. Changgeng Yi Xue Za Zhi 1996; 19: 181-186.
121. Podczaski E, Sees J, Kaminski P et al. Rhabdomyosarcoma of the uterus in a postmenopausal patient. Gynecol Oncol 1990; 37: 439-442.
122. Takano M, Kikuchi Y, Aida S, Sato K, Nagata I. Embryonal rhabdomyosarcoma of the uterine corpus in a 76-year-old patient. Gynecol Oncol 1999; 75: 490-494.
123. Emerich J, Senkus E, Konefka T. Alveolar rhabdomyosarcoma of the uterine cervix. Gynecol Oncol 1996; 63: 398-403.
124. Chiarle R, Godio L, Fusi D, Soldati T, Palestro G. Pure alveolar rhabdomyosarcoma of the corpus uteri: description of a case with increased serum level of CA-125. Gynecol Oncol 1997; 66: 320-323.
125. Young RH, Scully RE. Alveolar rhabdomyosarcoma metastatic to the ovary. A report of two cases and discussion of the differential diagnosis of small cell malignant tumors of the ovary. Cancer 1989; 64: 899-904.
126. Duran Padilla MA, Rodriguez Martinez HA, Chavez Mercado L, Soto Abraham MV, Ortega Gonzalez P, Medina Cruz A. [Atypical biological behavior of alveolar rhabdomyosarcoma in five patients]. Rev Invest Clin 1999; 51: 17-22.
127. Furlong MA, Mentzel T, Fanburg-Smith JC. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Mod Pathol 2001; 14: 595-603.
128. Miettinen M. Rhabdomyosarcoma in patients older than 40 years of age. Cancer 1988; 62: 2060-2065.
129. Colin D, Lazure T, Fabre M, De Watteville JC, Bedossa P. Pleomorphic rhabdomyosarcoma of the uterine corpus: a case report. Eur J Gynaecol Oncol 2001; 22: 116-117.
130. Holcomb K, Francis M, Ruiz J, Abulafia O, Matthews R P, Lee Y C. Pleomorphic rhabdomyosarcoma of the uterus in a postmenopausal woman with elevated serum CA125. Gynecol Oncol 1999; 74: 499-501.
131. Ordi J, Stamatakos MD, Tavassoli FA. Pure pleomorphic rhabdomyosarcomas of the uterus. Int J Gynecol Pathol 1997; 16: 369-377.
132. Banerjee SS, Harris M. Morphological and immunophenotypic variations in malignant melanoma. Histopathology 2000; 36: 387-402.
133. Lodding P, Kindblom L, Angervall L. Metastases of malignant melanoma simulating soft tissue sarcoma. Virchows Arch 1990; 417: 377-388.
134. Clark KC, Butz WR, Hapke MR. Primary malignant melanoma of the uterine cervix: case report with world literature review. Int J Gynecol Pathol 1999; 18: 265-273.
135. Deshpande AH, Munshi MM. Primary malignant melanoma of the uterine cervix: report of a case diagnosed by cervical scrape cytology and review of the literature. Diagn Cytopathol 2001; 25: 108-111.
136. Furuya M, Shimizu M, Nishihara H et al. Clear cell variant of malignant melanoma of the uterine cervix: a case report and review of the literature. Gynecol Oncol 2001; 80: 409-412.
137. Benson RJ, Tan LT. Radiation-induced malignant melanoma of the cervix. Clin Oncol (R Coll Radiol) 2000; 12: 234-237.